机构地区:[1]铜川矿务局中心医院消化内科,陕西铜川727000 [2]铜川市人民医院临床药学科,陕西铜川727100
出 处:《临床和实验医学杂志》2024年第24期2601-2604,共4页Journal of Clinical and Experimental Medicine
基 金:陕西省教育厅专项科研计划项目(编号:23JK0733)。
摘 要:目的探究盐酸依托必利片治疗对消化性溃疡患者的炎症因子、胃蛋白酶原表达的影响。方法前瞻性选取自2022年5月至2023年5月铜川矿务局中心医院收治的140例消化性溃疡患者作为研究对象,依据随机数字表法将患者分为对照组和观察组,各70例。对照组予以常规治疗(如口服奥美拉唑肠溶胶囊、胶体果胶铋胶囊;合并幽门螺杆菌感染者,口服阿莫西林胶囊、口服克拉霉素片),观察组在对照组治疗的基础上,加用盐酸依托必利片治疗,两组疗程均为14 d。比较两组患者的临床疗效,比较并检测两组患者治疗前及疗程结束后1 d的血清白细胞介素(IL)-1β、IL-2、IL-6、肿瘤坏死因子-α(TNF-α)、胃泌素17(G17)、胃蛋白酶原(PG)Ⅰ、PGⅡ水平,并比较两组不良反应发生情况。结果观察组临床总有效率为95.71%,高于对照组(87.14%),差异有统计学意义(P<0.05)。疗程结束后1 d,两组血清IL-1β、IL-2、IL-6、TNF-α水平均较治疗前降低,且观察组疗程结束后1 d的血清IL-1β、IL-2、IL-6、TNF-α水平分别为(32.12±3.27)ng/L、(30.12±4.27)ng/L、(28.74±3.25)ng/L、(22.30±2.83)pg/mL,均低于对照组[(46.87±5.14)ng/L、(43.25±6.18)ng/L、(41.35±6.51)ng/L、(36.47±4.70)pg/mL],差异均有统计学意义(P<0.05)。疗程结束后1 d,两组血清G17、PGⅡ水平均较治疗前降低,血清PGⅠ水平均较治疗前升高,差异均有统计学意义(P<0.05);观察组疗程结束后1 d的血清G17、PGⅡ水平分别为(14.26±2.03)pmol/L、(14.53±4.32)μg/L,均低于对照组[(18.79±3.78)pmol/L、(20.27±6.58)μg/L],PGⅠ水平为(125.85±25.72)μg/L,高于对照组[(105.16±17.84)μg/L],差异均有统计学意义(P<0.05)。两组患者的不良反应发生率比较,差异无统计学意义(P>0.05)。结论消化性溃疡患者使用盐酸依托必利片效果显著,可降低炎症因子的表达水平,改善胃蛋白酶原表达,且安全性较高。Objective To explore the effect of etopride hydrochloride tablets on the expression of inflammatory factors and pepsinogen in patients with peptic ulcer.Methods A total of 140 patients with peptic ulcer admitted to Tongchuan Mining Bureau Central Hospital from May 2022 to May 2023 were prospectively selected as the research objects.According to the random number table method,the patients were divided into the control group and the observation group,with 70 cases in each group.The control group received conventional treatment(such as oral omeprazole enteric capsule and colloidal pectin bismuth capsule;infected with Helicobacter pylori,oral amoxicillin capsule and oral clarithromycin tablet).The observation group was treated with ethopilide hydrochloride tablet on the basis of the control group.The course of both groups was 14 d.The clinical efficacy of the two groups was compared.The levels of serum interleukin(IL)-1β,IL-2,IL-6,tumor necrosis factor-α(TNF-α),gastrin 17(G17),pepsinogen(PG)I and PGⅡ before treatment and 1 d after treatment were detected and compared between the two groups,and the incidence of adverse reactions was compared between the two groups.Results The total effective rate of the observation group was 95.71%,which was higher than that of the control group(87.14%),and the difference was statistically significant(P<0.05).One day after the end of treatment,the levels of serum IL-1β,IL-2,IL-6 and TNF-α in the two groups were lower than those before treatment,and the levels of serum IL-1β,IL-2,IL-6 and TNF-α in the observation group were(32.12±3.27)ng/L,(30.12±4.27)ng/L,(28.74±3.25)ng/L and(22.30±2.83)pg/mL,respectively,which were lower than the control group[(46.87±5.14)ng/L,(43.25±6.18)ng/L,(41.35±6.51)ng/L,(36.47±4.70)pg/mL],the differences were statistically significant(P<0.05).One day after the end of treatment,the levels of serum G17 and PGⅡin the two groups were lower than those before treatment,and the levels of serum PGI were higher than those before treatment,the differe
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...